Yale targets COVID-19 with innovative computational design methods

A new class of antiviral agents developed shows promise for creating COVID-19 therapeutics — particularly effective when used with the drug remdesivir.

A new class of antiviral agents developed shows promise for creating COVID-19 therapeutics — particularly effective when used with the drug remdesivir.